Reising Ethington continues to seek and successfully obtain intellectual property protection for Cerephex products and trade names

While Reising client Cerephex¬ has been working through the final stages of obtaining FDA clearance to market their revolutionary NeuroPoint¬ product for the remediation of Fibromyalgia and other brain-related disorders, Reising Ethington continues to seek and successfully obtain intellectual property protection for Cerephex products and trade names. Recently, Reising attorney Eric Jones travelled with Cerephex¬ […]